Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a Consumer or other non HCP from product quality group.  A 66-year-old female patient (not pregnant) received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 20Oct2023 as dose 1, single (Batch/Lot number: unknown) at the age of 65 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Dilantin, reaction(s): "Drug allergy". Vaccination history included: BNT162b2 (vaccine brand: Pfizer / BioNTech,, vaccine brand unknown: False,, vaccine administration date: 06May2023,, vaccine lot number: GL2042,, vaccine lot unknown: False,, vaccine dose number unknown: True,, vaccine dose number unknown reason: UNKNOWN,, vaccine location: Left arm,), administration date: 06May2023, when the patient was 65-year-old, for Covid-19 Immunization; BNT162b2 (vaccine brand: Pfizer/BioNTech,, vaccine brand unknown: False,, vaccine administration date: 26Sep2022,, vaccine lot number: GJ2524,, vaccine lot unknown: False,, vaccine dose number unknown: True,, vaccine dose number unknown reason: UNKNOWN,, vaccine location: Left arm,), administration date: 26Sep2022, when the patient was 64-year-old, for Covid-19 Immunization; BNT162b2 (vaccine brand: Pfizer / BioNTech,, vaccine brand unknown: False,, vaccine administration date: 17May2022,, vaccine lot number: FJ4989,, vaccine lot unknown: False,, vaccine dose number unknown: True,, vaccine dose number unknown reason: UNKNOWN,, vaccine location: Left arm,), administration date: 17May2022, when the patient was 64-year-old, for Covid-19 Immunization; BNT162b2 (vaccine brand: Pfizer / BioNTech,, vaccine brand unknown: False,, vaccine administration date: 15Nov2021,, vaccine lot number: LW0178,, vaccine lot unknown: False,, vaccine dose number unknown: True,, vaccine dose number unknown reason: UNKNOWN,, vaccine location: Left arm,), administration date: 15Nov2021, when the patient was 64-year-old, for Covid-19 Immunization; BNT162b2 (vaccine brand: Pfizer / BioNTech,, vaccine brand unknown: False,, vaccine administration date: 27Apr2021,, vaccine lot number: EW0175,, vaccine lot unknown: False,, vaccine dose number unknown: True,, vaccine dose number unknown reason: UNKNOWN,, vaccine location: Left arm,), administration date: 27Apr2021, when the patient was 63-year-old, for Covid-19 Immunization; pfizer / biontech (vaccine brand: Pfizer / BioNTech,, vaccine brand unknown: False,, vaccine administration date: 09Apr2021,, vaccine lot number: EW0153,, vaccine lot unknown: False,, vaccine dose number unknown: True,, vaccine dose number unknown reason: UNKNOWN,, vaccine location: Left arm), administration date: 09Apr2021, when the patient was 63-year-old, for Covid-19 Immunization. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive; negative. Therapeutic measures were taken as a result of vaccination failure, covid-19.  The information on the batch/lot number for BNT162b2 omi xbb.1.5 will be requested and submitted if and when received.